Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes

Type 1 diabetes (T1D) results from autoimmune destruction of insulin producing β cells of the pancreatic islets. Curbing autoimmunity at the initiation of T1D can result in recovery of residual β cells and consequently remission of diabetes. Here we report a cell-based therapy for autoimmune diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalili, Reza B., Zhang, Yun, Hosseini-Tabatabaei, Azadeh, Kilani, Ruhangiz T., Khosravi Maharlooei, Mohsen, Li, Yunyuan, Salimi Elizei, Sanam, Warnock, Garth L., Ghahary, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713151/
https://www.ncbi.nlm.nih.gov/pubmed/26765526
http://dx.doi.org/10.1371/journal.pone.0146970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713151/
https://www.ncbi.nlm.nih.gov/pubmed/26765526
http://dx.doi.org/10.1371/journal.pone.0146970

Ejemplares similares